Figure 1.
Landscape of acquired alterations on FGFR inhibitors. A, Frequency of FGFR2 kinase domain mutations on FGFR inhibitors. Ribbon diagram (B) and schematic (C) showing location and overall frequency of the secondary FGFR2 kinase domain mutations. (B, Created with PyMOL. C, Created with BioRender.com.)